ArticleJournal of pharmacy & bioallied sciences2025
Incidence Prevalence Impact and Outcomes of Iron Deficiency Anemia in Pregnant Women: A Prospective Study.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: "Iron deficiency anemia (IDA)" is a common condition during pregnancy, which contributes to several adverse pregnancy outcomes, including preterm birth and low birth weight. To check the prevalence of IDA in pregnancy and to identify its influence on obstetrics outcomes, this research was planned. Methods: A cross-sectional study was carried out in 500 pregnant women who were in their second and third trimesters. Outcomes measured were hemoglobin levels, serum ferritin, and pregnancy outcomes. Results: The prevalence of IDA in the study was 35%. Women with IDA had significantly greater rates of preterm births and low birth weight infants. Mean hemoglobin levels were significantly lower in the IDA group. Conclusion: IDA is prevalent among pregnant women and has significant implications for pregnancy outcomes, particularly in terms of preterm delivery and low birth weight. Early detection and management of IDA can improve maternal and fetal health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.